| Primary |
| Gitelman's Syndrome |
25.0% |
| Type 2 Diabetes Mellitus |
25.0% |
| Drug Use For Unknown Indication |
16.7% |
| Blood Potassium Decreased |
8.3% |
| Computerised Tomogram |
8.3% |
| Mineral Supplementation |
8.3% |
| Pancreatic Carcinoma Metastatic |
8.3% |
|
| Adverse Event |
25.0% |
| Food Allergy |
25.0% |
| Hyperkalaemia |
25.0% |
| Renal Failure Acute |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
11.9% |
| Diabetes Mellitus |
8.3% |
| Chest Pain |
7.1% |
| Convulsion |
7.1% |
| Crohn's Disease |
7.1% |
| Antiemetic Supportive Care |
6.0% |
| Blood Cholesterol Increased |
4.8% |
| Cardiac Disorder |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Gitelman's Syndrome |
3.6% |
| Hypertension |
3.6% |
| Insomnia |
3.6% |
| Migraine |
3.6% |
| Muscle Spasms |
3.6% |
| Nausea |
3.6% |
| Nervousness |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Plasma Cell Myeloma |
3.6% |
| Acute Coronary Syndrome |
2.4% |
|
| Off Label Use |
14.3% |
| Alopecia |
7.1% |
| Basal Cell Carcinoma |
7.1% |
| Death |
7.1% |
| Dysphagia |
7.1% |
| Emphysema |
7.1% |
| Food Allergy |
7.1% |
| Hypokalaemia |
7.1% |
| Migraine |
7.1% |
| Product Quality Issue |
7.1% |
| Tooth Abscess |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.1% |
| Drug Use For Unknown Indication |
27.9% |
| Hypertension |
4.8% |
| Pain |
4.6% |
| Pulmonary Arterial Hypertension |
2.5% |
| Multiple Myeloma |
2.4% |
| Nausea |
2.3% |
| Prophylaxis |
1.9% |
| Depression |
1.8% |
| Rheumatoid Arthritis |
1.4% |
| Atrial Fibrillation |
1.4% |
| Diabetes Mellitus |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Anxiety |
1.4% |
| Constipation |
1.2% |
| Osteoporosis |
1.2% |
| Breast Cancer |
1.1% |
| Supplementation Therapy |
1.1% |
| Nuclear Magnetic Resonance Imaging |
1.0% |
| Type 2 Diabetes Mellitus |
0.9% |
|
| Vomiting |
17.3% |
| Weight Decreased |
10.4% |
| Pneumonia |
7.3% |
| Weight Increased |
6.6% |
| Death |
6.0% |
| Urinary Tract Infection |
5.8% |
| X-ray Abnormal |
4.4% |
| Unevaluable Event |
4.0% |
| Myocardial Infarction |
3.7% |
| Ventricular Tachycardia |
3.6% |
| Viral Infection |
3.6% |
| Oedema Peripheral |
3.4% |
| Renal Failure |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Vision Blurred |
3.0% |
| Wheezing |
3.0% |
| Pain |
2.9% |
| Dyspnoea |
2.7% |
| Syncope |
2.7% |
|
